TELO
Telomir Pharmaceuticals, Inc.
1.20$
-0.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -57.1% | -33.3% | +239.1% | -115.9% | – | -95.2% | +499.3% | – | |
| – | – | -201.5% | – | – | -18.4% | -130.2% | – | – | +1,028.7% | -194.8% | – | – | |
| – | – | +0.0% | -100.0% | – | – | -100.0% | – | +25.0% | -40.0% | -100.0% | – | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | +30.4% | +203.5% | – | |
| – | -45.5% | +380.0% | -97.5% | -135.4% | – | -100.0% | – | +616.0% | -84.6% | -95.9% | +1,213.8% | – | |
| – | – | – | -142.5% | – | – | -300.0% | – | +1,771.5% | -100.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.